The function and regulation network mechanism of circRNA in liver diseases

被引:10
|
作者
Wang, Panpan [1 ,3 ]
Zhang, Yunhuan [2 ]
Deng, Lugang [3 ]
Qu, Zhi [2 ]
Guo, Peisen [1 ,3 ]
Liu, Limin [1 ,2 ,3 ]
Yu, Zengli [1 ]
Wang, Peixi [2 ]
Liu, Nan [1 ,2 ,3 ]
机构
[1] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou 540001, Peoples R China
[2] Henan Univ, Inst Chron Dis Risks Assessment, Sch Nursing & Hlth, Kaifeng 475004, Peoples R China
[3] Shenzhen Univ, South China Hosp, Hlth Sci Ctr, Shenzhen 518116, Peoples R China
基金
中国国家自然科学基金;
关键词
circRNA; Liver diseases; Hepatocellular carcinoma (HCC); Biomarker; miRNA sponge; DETECTING CIRCULAR RNAS; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; SIGNALING PATHWAY; DOWN-REGULATION; ONCOGENIC GENE; TUMOR-GROWTH; CANCER; PROGRESSION; BIOMARKERS;
D O I
10.1186/s12935-022-02559-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circular RNA (circRNA), a new type of endogenous non-coding RNA, is abundantly present in eukaryotic cells, and characterized as stable high conservation and tissue specific expression. It has been generated increasing attention because of their close association with the progress of diseases. The liver is the vital organ of humans, while it is prone to acute and chronic diseases due to the influence of multiple pathogenic factors. Moreover, hepatocellular carcinoma (HCC) is the one of most common cancer and the leading cause of cancer death worldwide. Overwhelming evidences indicate that some circRNAs are differentially expressed in liver diseases, such as, HCC, chronic hepatitis B, hepatic steatosis and hepatoblastoma tissues, etc. Additionally, these circRNAs are related to proliferation, invasion, migration, angiogenesis, apoptosis, and metastasis of cell in liver diseases and act as oncogenic agents or suppressors, and linked to clinical manifestations. In this review, we briefly summarize the biogenesis, characterization and biological functions, recent detection and identification technologies of circRNA, and regulation network mechanism of circRNA in liver diseases, and discuss their potential values as biomarkers or therapeutic targets for liver diseases, especially on HCC.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] The function and mechanism of LAPTM5 in diseases
    Zhang, Man-man
    Liang, Ming-jun
    Zhang, Dong-mei
    Cai, Jun-nan
    Yang, Quan-jun
    Zhao, Yun
    Zhang, Jian-ping
    Li, Yang-ling
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 178
  • [42] Construction of circRNA-associated ceRNA network reveals the regulation of fibroblast proliferation in cervical cancer
    Sun, Wei
    Hang, Dong
    Han, Suping
    Fu, Shilong
    Ma, Hongxia
    Dong, Xuesi
    Xu, Yongjie
    Li, Ni
    Hu, Zhibin
    GENE, 2022, 844
  • [43] The mechanism and function of circular RNAs in human diseases
    Lei, Kexin
    Bai, Hetian
    Wei, Zihao
    Xie, Changqing
    Wang, Jiongke
    Li, Jing
    Chen, Qianming
    EXPERIMENTAL CELL RESEARCH, 2018, 368 (02) : 147 - 158
  • [44] circRNA is a potential target for cardiovascular diseases treatment
    Jie Ju
    Ya-nan Song
    Xin-zhe Chen
    Tao Wang
    Cui-yun Liu
    Kun Wang
    Molecular and Cellular Biochemistry, 2022, 477 : 417 - 430
  • [45] Potential mechanism of circRNA 000585 in cholangiocarcinoma
    Yi, F.
    Feng, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S131 - S131
  • [46] MECHANISM AND REGULATION OF PROTEIN-DEGRADATION IN LIVER
    MORTIMORE, GE
    POSO, AR
    LARDEUX, BR
    DIABETES-METABOLISM REVIEWS, 1989, 5 (01): : 49 - 70
  • [47] circRNA is a potential target for cardiovascular diseases treatment
    Ju, Jie
    Song, Ya-nan
    Chen, Xin-zhe
    Wang, Tao
    Liu, Cui-yun
    Wang, Kun
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2022, 477 (02) : 417 - 430
  • [48] METABOLIC ZONATION OF THE LIVER - REGULATION AND IMPLICATIONS FOR LIVER-FUNCTION
    GEBHARDT, R
    PHARMACOLOGY & THERAPEUTICS, 1992, 53 (03) : 275 - 354
  • [49] Endocannabinoids signaling: Molecular mechanisms of liver regulation and diseases
    Wang, Mi
    Meng, Nan
    Chang, Ying
    Tang, Wangxian
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 1488 - 1501
  • [50] PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs
    Peyrou, Marion
    Ramadori, Pierluigi
    Bourgoin, Lucie
    Foti, Michelangelo
    PPAR RESEARCH, 2012, 2012